Ysios Capital is an early-stage venture capital firm focused exclusively on life sciences, investing in European healthcare and biotechnology startups. With €191 million in assets under management, the firm typically invests €1M–€7M per company.
Ysios Capital focuses on highly innovative companies creating transformative technologies in pharmaceuticals, biotechnology, medical devices, and healthcare technology. The firm takes a hands-on approach, working closely with management teams to accelerate growth.
Based in Barcelona and Madrid, Ysios Capital leverages Spain's growing biotech ecosystem and world-class research institutions (including Hospital Clínic, CNIO, and IRB Barcelona) to identify breakthrough innovations at the intersection of science and medicine.
Barcelona, Spain
"Pushing the boundaries of science and medicine — investing in transformative life sciences from Barcelona to all of Europe."
Apply to the Apex Startup Discovery Program
Aligned with Ysios Capital's investment focus. Precondition: You must be an Apex Participant to submit. Registration is complimentary and includes 2 Golden Ads. This project is part of Apex Master Expos.
Apex Ecosystem with Golden Ads
"Who I Am · What I Want"
Complimentary for Apex Participants at myapex.me — includes 2 Golden Ads. Part of Apex Master Expos.
Apex is a living ecosystem — one of its kind. A decentralized, member-owned global business platform across 80+ countries where preferred venture partners such as Ysios Capital can explore early-stage innovation quietly and selectively, while founders showcase on their MySite and gain clarity on what long-term investors truly seek. No middleman. By members, for members.